BA
52
2
PEP
41
6
IP
70
2
ED
48
3
RRC
63
3
PVH
52
-3
KMX
58
3
IR
63
3
MCO
73
3
INTC
35
-2
IVZ
46
3
AIG
38
-4
LLY
39
9
BAC
50
-3
DVN
16
3
ACN
47
-2
JWN
40
-2
XYL
37
2
SCHW
64
2
IPG
49
10
BA
52
2
PEP
41
6
IP
70
2
ED
48
3
RRC
63
3
PVH
52
-3
KMX
58
3
IR
63
3
MCO
73
3
INTC
35
-2
IVZ
46
3
AIG
38
-4
LLY
39
9
BAC
50
-3
DVN
16
3
ACN
47
-2
JWN
40
-2
XYL
37
2
SCHW
64
2
IPG
49
10
Financhill
Back

GlycoMimetics Vs. Revance Therapeutics Industry Stock Comparison

Sell
50

GLYC
GlycoMimetics

Last Price:
0.32
Seasonality Move:
31.73%
Sell
10

RVNC
Revance Therapeutics

Last Price:
3.84
Seasonality Move:
2.15%
Sell
50
GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

  • The current GlycoMimetics [GLYC] share price is $0.33. The Score for GLYC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
10
Revance Therapeutics (RVNC) is a Sell

Is Revance Therapeutics a Buy, Sell or Hold?

  • The current Revance Therapeutics [RVNC] share price is $3.80. The Score for RVNC is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
  • RVNC is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

  • The GlycoMimetics share price today is $0.33
    The current trend is moderately bearish and GLYC is experiencing slight selling pressure.

RVNC Stock Price Chart

What is Revance Therapeutics's stock price today?

  • The Revance Therapeutics share price today is $3.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RVNC is experiencing slight selling pressure.

GLYC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 49.57 Sell
Chaikin Money Flow: -1087514 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.22 - 0.44) Sell
Bollinger Bands (100): (0.14 - 0.32) Buy

RVNC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.44 Sell
Relative Strength Index (14 RSI): 33.4 Sell
Chaikin Money Flow: -30034 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.15 - 5.83) Sell
Bollinger Bands (100): (3.71 - 6.29) Sell

GLYC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.4 Sell
20-day SMA: 0.37 Sell
50-day SMA: 0.24 Buy
200-day SMA: 0.99 Sell
8-day EMA: 0.38 Sell
20-day EMA: 0.35 Sell
50-day EMA: 0.3 Buy
200-day EMA: 0.74 Sell

RVNC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.98 Sell
20-day SMA: 4.91 Sell
50-day SMA: 5.27 Sell
200-day SMA: 4.62 Sell
8-day EMA: 4.13 Sell
20-day EMA: 4.63 Sell
50-day EMA: 5.02 Sell
200-day EMA: 6.06 Sell

GlycoMimetics Earnings Growth & GLYC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Revance Therapeutics Earnings Growth & RVNC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.51 per share, and an increase next year of $0.58 per share.

GlycoMimetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Revance Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):